NYSE:VAR - Varian Medical Systems Stock Price, Price Target & More

$126.76 -0.03 (-0.02 %)

(As of 04/20/2018 02:12 PM ET)

Previous Close$126.79

Today's Range$125.79 - $127.02

52-Week Range$87.49 - $130.29

Volume253,092 shs

Average Volume735,706 shs

Market Capitalization$11.52 billion

P/E Ratio35.07

Dividend YieldN/A

Beta0.82

About Varian Medical Systems (NYSE:VAR)

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. Its products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, oncology practices, radiotherapy centers, and cancer care clinics. The Varian Particle Therapy segment develops, designs, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. Varian Medical Systems, Inc. has a strategic partnership with Siemens AG to co-develop new imaging and treatment solutions. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.

Receive VAR News and Ratings via Email

Sign-up to receive the latest news and ratings for VAR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment

Sub-IndustryHealth Care Equipment

SectorMedical

SymbolNYSE:VAR

CUSIP92220P10

Webwww.varian.com

Phone650-493-4000

Debt

Debt-to-Equity RatioN/A

Current Ratio1.45%

Quick Ratio1.19%

Price-To-Earnings

Trailing P/E Ratio35.07

Forward P/E Ratio29.41

P/E Growth3.66

Sales & Book Value

Annual Sales$2.67 billion

Price / Sales4.34

Cash Flow$4.5110 per share

Price / Cash28.10

Book Value$16.33 per share

Price / Book7.76

Profitability

EPS (Most Recent Fiscal Year)$3.60

Net Income$249.60 million

Net Margins4.27%

Return on Equity27.13%

Return on Assets11.95%

Miscellaneous

Employees6,600

Outstanding Shares91,300,000

How to Become a New Pot Stock Millionaire

Varian Medical Systems (NYSE:VAR) Frequently Asked Questions

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems (NYSE:VAR) released its quarterly earnings data on Wednesday, January, 24th. The medical equipment provider reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.06. The medical equipment provider earned $678.50 million during the quarter, compared to the consensus estimate of $633.96 million. Varian Medical Systems had a net margin of 4.27% and a return on equity of 27.13%. Varian Medical Systems's revenue for the quarter was up 12.8% on a year-over-year basis. During the same period in the previous year, the firm earned $1.09 earnings per share. View Varian Medical Systems' Earnings History.

When is Varian Medical Systems' next earnings date?

Varian Medical Systems is scheduled to release their next quarterly earnings announcement on Wednesday, April, 25th 2018. View Earnings Estimates for Varian Medical Systems.

What guidance has Varian Medical Systems issued on next quarter's earnings?

Varian Medical Systems issued an update on its FY18 earnings guidance on Wednesday, January, 24th. The company provided earnings per share (EPS) guidance of $4.24-4.36 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.22. The company issued revenue guidance of $2.774-2.854 billion, compared to the consensus revenue estimate of $2.75 billion.

What price target have analysts set for VAR?

11 brokers have issued 1-year price targets for Varian Medical Systems' stock. Their predictions range from $91.00 to $132.00. On average, they anticipate Varian Medical Systems' share price to reach $108.4444 in the next year. View Analyst Ratings for Varian Medical Systems.

Who are some of Varian Medical Systems' key competitors?

Some companies that are related to Varian Medical Systems include Sonova (SONVY), Masimo (MASI), LivaNova (LIVN), CONMED (CNMD), NxStage (NXTM), AxoGen (AXGN), Natus Medical (BABY), Cutera (CUTR), Viewray (VRAY), Rockwell Medical (RMTI), Vision Sciences (CGNT), Helius Medical Technologies (HSDT), Zynex (ZYXI), Biolife Solutions (BLFS), Viveve Medical (VIVE), Second Sight Medical (EYES), Edap Tms (EDAP) and IRIDEX (IRIX).

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the folowing people:

Mr. Gary E. Bischoping Jr., Sr. VP of Fin. & CFO (Age 50)
Mr. Dow R. Wilson, Pres, CEO & Director (Age 59)
Mr. Patrick Joda, Sr. VP of Global Operations (Age 60)
Mr. Magnus A. Momsen, Sr. VP, Chief Accounting Officer & Corp. Controller
Mr. Corey Zankowski Ph.D., Chief Technology Innovation Officer and Sr. VP

Has Varian Medical Systems been receiving favorable news coverage?

Press coverage about VAR stock has trended somewhat positive recently, according to Accern. The research firm identifies negative and positive media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Varian Medical Systems earned a coverage optimism score of 0.12 on Accern's scale. They also assigned media headlines about the medical equipment provider an impact score of 45.41 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.

How do I buy shares of Varian Medical Systems?

Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of VAR stock can currently be purchased for approximately $126.65.

How big of a company is Varian Medical Systems?

Varian Medical Systems has a market capitalization of $11.52 billion and generates $2.67 billion in revenue each year. The medical equipment provider earns $249.60 million in net income (profit) each year or $3.60 on an earnings per share basis. Varian Medical Systems employs 6,600 workers across the globe.

How can I contact Varian Medical Systems?

Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]

MarketBeat Community Rating for Varian Medical Systems (VAR)

Community Ranking:		2.6 out of 5 ( )
Outperform Votes:		370 (Vote Outperform)
Underperform Votes:		338 (Vote Underperform)
Total Votes:		708

MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe VAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VAR will underperform the S&P 500 over the long term. You may vote once every thirty days.

Varian Medical Systems (NYSE:VAR) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

11 Wall Street analysts have issued ratings and price targets for Varian Medical Systems in the last 12 months. Their average twelve-month price target is $108.4444, suggesting that the stock has a possible downside of 14.45%. The high price target for VAR is $132.00 and the low price target for VAR is $91.00. There are currently 3 sell ratings, 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Hold
Consensus Rating Score:	2.00	2.00	1.90	2.00
Ratings Breakdown:	3 Sell Rating(s) 5 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	3 Sell Rating(s) 5 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 7 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 6 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$108.4444	$108.4444	$100.4444	$94.9375
Price Target Upside:	14.45% downside	16.23% downside	9.49% downside	11.05% downside

Varian Medical Systems (NYSE:VAR) Consensus Price Target History

Price Target History for Varian Medical Systems (NYSE:VAR)

Varian Medical Systems (NYSE:VAR) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/10/2018	Royal Bank of Canada	Set Price Target	Hold	$115.00	Low
1/28/2018	BTIG Research	Reiterated Rating	Neutral -> Hold		Low
1/25/2018	JPMorgan Chase	Boost Price Target	Neutral -> Neutral	$88.00 -> $105.00	Low
1/25/2018	Barrington Research	Upgrade	Market Perform -> Outperform	$130.00	High
1/25/2018	Citigroup	Boost Price Target	Neutral -> Buy	$128.00 -> $132.00	High
1/25/2018	Goldman Sachs	Downgrade	Neutral -> Sell	$98.00	High
1/3/2018	Evercore ISI	Initiated Coverage	Underperform -> Underperform	$100.00	Low
8/28/2017	Robert W. Baird	Reiterated Rating	Hold	$99.00	Low
5/17/2017	Aegis	Reiterated Rating	Hold	$91.00	Low
5/11/2017	Jefferies Group	Reiterated Rating	Buy		Low
4/24/2017	Off Wall Street	Initiated Coverage	Sell		Low
7/28/2016	Morgan Stanley	Boost Price Target	Underweight	$80.00 -> $86.00	N/A
7/28/2016	Brean Capital	Boost Price Target	Buy	$87.00 -> $90.00	N/A

(Data available from 4/20/2016 forward)

Varian Medical Systems (NYSE:VAR) Earnings History and Estimates Chart

Earnings by Quarter for Varian Medical Systems (NYSE:VAR)

Varian Medical Systems (NYSE:VAR) Earnings Estimates

2018 EPS Consensus Estimate: $4.22

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	2	$0.92	$1.00	$0.96
Q2 2018	2	$0.94	$1.03	$0.99
Q3 2018	2	$1.01	$1.05	$1.03
Q4 2018	2	$1.23	$1.26	$1.25

Varian Medical Systems (NYSE VAR) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
4/24/2018		$1.05					N/A
1/24/2018	Q1 2018	$1.00	$1.06	$633.96 million	$678.50 million	View	Listen
10/25/2017	Q4 2017	$1.19	$1.09	$741.69 million	$739.00 million	View	N/A
7/26/2017	Q3 2017	$0.95	$1.04	$663.86 million	$662.40 million	View	N/A
4/26/2017	Q2 2017	$0.88	$0.89	$639.26 million	$655.00 million	View	N/A
1/25/2017	Q1 2017	$1.05	$0.75	$768.62 million	$763.30 million	View	N/A
10/26/2016	Q4112	$1.34	$1.38	$880.29 million	$912.00 million	View	Listen
7/27/2016	Q316	$1.17	$1.22	$779.90 million	$789.40 million	View	Listen
4/27/2016	Q216	$1.08	$1.09	$769.56 million	$758.80 million	View	Listen
1/27/2016	Q116	$0.94	$0.99	$748.01 million	$757.00 million	View	Listen
10/28/2015	Q4	$1.10	$1.04	$813.18 million	$817.80 million	View	Listen
7/29/2015	Q3	$1.0980	$1.13	$810.41 million	$784.00 million	View	Listen
4/29/2015	Q215	$1.00	$1.05	$799.66 million	$759.40 million	View	N/A
1/28/2015	Q115	$0.87	$0.99	$720.83 million	$737.90 million	View	N/A
10/22/2014	Q415	$1.21	$1.02	$837.86 million	$812.10 million	View	Listen
7/23/2014	Q314	$1.09	$1.08	$767.52 million	$747.70 million	View	N/A
4/23/2014	Q4112	$1.03	$1.04	$772.84 million	$779.00 million	View	N/A
1/22/2014	Q3112	$0.90	$0.91	$718.23 million	$712.00 million	View	N/A
10/23/2013	Q3112	$1.12	$1.08	$779.02 million	$770.00 million	View	N/A
7/24/2013	Q3 2013	$1.01	$1.03	$749.01 million	$726.20 million	View	N/A
4/24/2013	Q2 2013	$1.02	$1.04	$758.02 million	$768.40 million	View	N/A
1/23/2013	Q1 2013	$0.87	$0.86	$676.15 million	$678.40 million	View	N/A
10/25/2012		$1.03	$1.08			View	N/A
7/25/2012		$0.94	$0.96			View	N/A
4/25/2012		$0.96	$0.96			View	N/A
1/25/2012		$0.75	$0.79			View	N/A
10/27/2011		$0.97	$0.95			View	N/A
7/27/2011		$0.83	$0.83			View	N/A
4/27/2011		$0.85	$0.86			View	N/A
1/26/2011		$0.73	$0.80			View	N/A
10/28/2010	Q4 2010	$0.84	$0.87			View	N/A
7/28/2010	Q3 2010	$0.65	$0.74			View	N/A
4/28/2010	Q2 2010	$0.68	$0.73			View	N/A
1/27/2010	Q1 2010	$0.56	$0.63			View	N/A
10/29/2009	Q4 2009	$0.75	$0.78			View	N/A
7/29/2009	Q3 2009	$0.63	$0.68			View	N/A
4/29/2009	Q2 2009	$0.60	$0.64			View	N/A
1/29/2009	Q1 2009	$0.51	$0.56			View	N/A
10/23/2008	Q4 2008	$0.65	$0.68			View	N/A
7/23/2008	Q3 2008	$0.46	$0.58			View	N/A
4/23/2008	Q2 2008	$0.51	$0.56			View	N/A
1/23/2008	Q1 2008	$0.40	$0.43			View	N/A

(Earnings results data provided by Zacks Investment Research)

Varian Medical Systems (NYSE:VAR) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Varian Medical Systems (NYSE VAR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.78%
Institutional Ownership Percentage: 99.09%

Insider Trading History for Varian Medical Systems (NYSE:VAR)

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Varian Medical Systems (NYSE VAR) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/16/2018	John W Kuo	SVP	Sell	1,328	$121.94	$161,936.32	30,708
4/10/2018	Kolleen T Kennedy	EVP	Sell	699	$120.33	$84,110.67	27,361
3/15/2018	John W Kuo	SVP	Sell	1,328	$125.51	$166,677.28	30,708
3/12/2018	Kolleen T Kennedy	EVP	Sell	699	$126.47	$88,402.53	27,361
3/12/2018	Magnus Momsen	CAO	Sell	1,556	$126.47	$196,787.32	6,588
3/6/2018	David J Illingworth	Director	Sell	5,651	$122.56	$692,586.56	12,737
3/1/2018	Dow R Wilson	Insider	Sell	24,000	$118.03	$2,832,720.00	99,356
2/22/2018	Susan L Bostrom	Director	Sell	1,952	$120.60	$235,411.20	3,809
2/16/2018	Kolleen T Kennedy	EVP	Sell	3,513	$121.16	$425,635.08	28,899
2/15/2018	John W Kuo	SVP	Sell	6,442	$120.67	$777,356.14	28,224
2/12/2018	Kolleen T Kennedy	EVP	Sell	8,390	$116.47	$977,183.30	35,052
2/1/2018	Dow R Wilson	Insider	Sell	24,000	$126.73	$3,041,520.00	90,776
2/1/2018	Mark R. Laret	Director	Sell	2,161	$126.97	$274,382.17
1/16/2018	John W Kuo	SVP	Sell	863	$108.43	$93,575.09	28,224
1/16/2018	Kolleen T Kennedy	EVP	Sell	933	$108.31	$101,053.23	27,595
1/12/2018	Kolleen T Kennedy	EVP	Sell	1,089	$108.19	$117,818.91	27,751
1/8/2018	John W Kuo	SVP	Sell	7,991	$110.65	$884,204.15	27,363
1/2/2018	Timothy E Guertin	Director	Sell	10,000	$111.46	$1,114,600.00	2,161
12/18/2017	Dow R Wilson	Insider	Sell	88,766	$111.00	$9,853,026.00	155,542
12/13/2017	Kolleen T Kennedy	EVP	Sell	2,018	$111.97	$225,955.46	27,749
11/13/2017	Kolleen T Kennedy	EVP	Sell	2,021	$107.36	$216,974.56	27,595
10/18/2017	Kolleen T Kennedy	EVP	Sell	931	$105.00	$97,755.00	27,531
10/12/2017	Kolleen T Kennedy	EVP	Sell	1,088	$101.55	$110,486.40
10/6/2017	Dow R Wilson	Insider	Sell	15,059	$102.40	$1,542,041.60
10/6/2017	R Andrew Eckert	Director	Sell	5,651	$102.39	$578,605.89
9/13/2017	Kolleen T Kennedy	EVP	Sell	933	$107.29	$100,101.57	27,533
9/12/2017	Kolleen T Kennedy	EVP	Sell	1,088	$107.33	$116,775.04	27,688
9/7/2017	Dow R Wilson	Insider	Sell	15,059	$105.41	$1,587,369.19	81,835
8/31/2017	Kolleen T Kennedy	EVP	Sell	931	$105.00	$97,755.00	27,531
8/14/2017	Kolleen T Kennedy	EVP	Sell	1,088	$97.91	$106,526.08	26,600
8/7/2017	Dow R Wilson	Insider	Sell	15,059	$96.48	$1,452,892.32	81,835
7/13/2017	John W Kuo	SVP	Sell	1,597	$104.43	$166,774.71	28,224
7/13/2017	Kolleen T Kennedy	EVP	Sell	2,021	$104.73	$211,659.33	27,688
7/12/2017	John W Kuo	SVP	Sell	863	$104.48	$90,166.24	28,224
7/12/2017	Kolleen T Kennedy	EVP	Sell	1,088	$104.49	$113,685.12	27,688
7/10/2017	Dow R Wilson	Insider	Sell	15,060	$103.37	$1,556,752.20	81,836
6/20/2017	Kolleen T Kennedy	EVP	Sell	26,092	$105.00	$2,739,660.00	52,692
6/13/2017	John W Kuo	SVP	Sell	734	$101.91	$74,801.94	28,095
6/12/2017	John W Kuo	SVP	Sell	863	$101.25	$87,378.75	28,224
6/12/2017	Kolleen T Kennedy	EVP	Sell	1,087	$101.20	$110,004.40	27,687
6/9/2017	Timothy E Guertin	Director	Sell	16,000	$103.22	$1,651,520.00	2,161
6/8/2017	Mark R Laret	Director	Sell	1,428	$103.47	$147,755.16	3,289
6/1/2017	Kolleen T Kennedy	EVP	Sell	56,573	$99.76	$5,643,722.48	32,737
5/31/2017	John W Kuo	SVP	Sell	19,819	$99.67	$1,975,359.73	47,180
5/12/2017	John W Kuo	SVP	Sell	862	$96.39	$83,088.18	28,223
5/2/2017	Susan L Bostrom	Director	Sell	3,589	$91.08	$326,886.12	3,809
4/12/2017	John W Kuo	SVP	Sell	864	$89.74	$77,535.36	27,914
3/17/2017	John W Kuo	SVP	Sell	3,876	$91.75	$355,623.00	30,926
3/13/2017	John W Kuo	SVP	Sell	862	$87.89	$75,761.18	27,912
3/1/2017	John W Kuo	SVP	Sell	10,353	$84.81	$878,037.93	37,403
1/5/2017	Dow R Wilson	Insider	Sell	13,334	$88.74	$1,183,259.16	77,625
12/8/2016	John W Kuo	SVP	Sell	1,267	$90.33	$114,448.11	24,027
12/5/2016	Dow R Wilson	Insider	Sell	10,000	$90.03	$900,300.00	74,291
11/7/2016	Dow R Wilson	Insider	Sell	10,000	$90.59	$905,900.00	70,598
10/31/2016	Timothy E Guertin	Director	Sell	4,000	$90.32	$361,280.00
10/20/2016	John W Kuo	SVP	Sell	21,266	$103.70	$2,205,284.20	45,293
10/5/2016	Dow R Wilson	Insider	Sell	10,000	$99.44	$994,400.00	70,598
10/3/2016	Elisha W Finney	CFO	Sell	4,668	$98.87	$461,525.16	9,863
9/15/2016	John W Kuo	SVP	Sell	4,073	$95.47	$388,849.31	28,100
9/7/2016	Elisha W Finney	CFO	Sell	9,000	$96.95	$872,550.00	14,195
9/6/2016	Dow R Wilson	Insider	Sell	10,000	$96.08	$960,800.00	70,598
9/1/2016	Elisha W Finney	CFO	Sell	2,000	$95.82	$191,640.00	7,195
8/5/2016	Dow R Wilson	Insider	Sell	10,000	$95.14	$951,400.00	70,598
8/1/2016	Clarence R Verhoef	SVP	Sell	9,483	$94.88	$899,747.04	8,616
8/1/2016	Elisha W Finney	CFO	Sell	25,334	$94.90	$2,404,196.60	7,195
8/1/2016	Timothy E. Guertin	Director	Sell	4,000	$94.88	$379,520.00
7/5/2016	Dow R Wilson	CEO	Sell	10,000	$82.08	$820,800.00	70,598
6/27/2016	Dow R Wilson	CEO	Sell	10,000	$78.27	$782,700.00	70,598
6/8/2016	Ruediger Naumann-Etienne	Director	Sell	1,000	$84.83	$84,830.00
6/3/2016	Mark R Laret	Director	Sell	1,545	$83.48	$128,976.60	1,428
5/2/2016	Timothy E. Guertin	Director	Sell	4,000	$81.55	$326,200.00
4/20/2016	Elisha W Finney	CFO	Sell	4,000	$85.95	$343,800.00	9,011
4/18/2016	Clarence R Verhoef	SVP	Sell	2,500	$85.00	$212,500.00	8,445
3/23/2016	Dow R Wilson	CEO	Sell	45,650	$78.86	$3,599,959.00	105,931
3/10/2016	Ruediger Naumann-Etienne	Director	Sell	428	$77.99	$33,379.72	1,000
3/7/2016	Timothy E. Guertin	Director	Sell	4,000	$79.47	$317,880.00
2/17/2016	Elisha W. Finney	CFO	Sell	2,454	$78.59	$192,859.86	5,011
12/7/2015	Dow R. Wilson	CEO	Sell	9,000	$80.00	$720,000.00	44,943
12/2/2015	R Andrew Eckert	Director	Sell	3,000	$81.67	$245,010.00	7,016
11/24/2015	Elisha W. Finney	CFO	Sell	2,334	$80.90	$188,820.60	5,011
11/6/2015	Dow R. Wilson	CEO	Sell	18,000	$80.26	$1,444,680.00	38,767
9/8/2015	Dow R. Wilson	CEO	Sell	9,000	$80.05	$720,450.00	38,767
7/6/2015	Dow R Wilson	CEO	Sell	9,000	$85.80	$772,200.00
7/2/2015	Elisha W Finney	CFO	Sell	2,000	$85.95	$171,900.00
7/1/2015	Timothy E Guertin	Director	Sell	25,000	$84.20	$2,105,000.00
6/5/2015	Dow R Wilson	CEO	Sell	9,000	$86.29	$776,610.00
6/1/2015	Elisha W Finney	CFO	Sell	2,000	$85.99	$171,980.00
6/1/2015	Timothy E Guertin	Director	Sell	25,000	$86.08	$2,152,000.00
5/6/2015	Dow R Wilson	CEO	Sell	9,000	$86.64	$779,760.00
4/17/2015	Dow R Wilson	CEO	Sell	18,760	$93.63	$1,756,498.80
4/1/2015	Elisha W Finney	CFO	Sell	5,000	$92.76	$463,800.00
4/1/2015	Timothy E Guertin	Director	Sell	25,000	$92.76	$2,319,000.00
3/20/2015	Dow R Wilson	CEO	Sell	18,759	$94.44	$1,771,599.96
3/16/2015	Kolleen T Kennedy	EVP	Sell	1,972	$95.00	$187,340.00
3/6/2015	Timothy E Guertin	Director	Sell	4,000	$93.50	$374,000.00
3/2/2015	Elisha W Finney	CFO	Sell	5,000	$93.44	$467,200.00
3/2/2015	Timothy E Guertin	Director	Sell	50,000	$93.48	$4,674,000.00
2/23/2015	Elisha W Finney	CFO	Sell	1,326	$92.97	$123,278.22
2/10/2015	Mark R Laret	Director	Sell	10,000	$92.32	$923,200.00
2/3/2015	Venkatraman Thyagarajan	Director	Sell	10,000	$92.71	$927,100.00
2/2/2015	Dow R Wilson	CEO	Sell	60,000	$91.78	$5,506,800.00
2/2/2015	Elisha W Finney	CFO	Sell	6,667	$91.79	$611,963.93
2/2/2015	John W Kuo	SVP	Sell	3,490	$92.04	$321,219.60
2/2/2015	Ruediger Naumann-Etienne	Director	Sell	10,000	$91.87	$918,700.00
1/5/2015	Timothy E Guertin	Director	Sell	50,000	$86.27	$4,313,500.00
1/2/2015	Elisha W Finney	CFO	Sell	15,000	$87.05	$1,305,750.00
12/11/2014	Timothy E Guertin	Director	Sell	105,000	$86.67	$9,100,350.00
12/1/2014	Elisha W Finney	CFO	Sell	21,000	$88.72	$1,863,120.00
11/24/2014	Elisha W Finney	CFO	Sell	2,930	$88.24	$258,543.20
11/17/2014	Elisha W Finney	CFO	Sell	1,837	$87.71	$161,123.27
11/11/2014	Kolleen T Kennedy	SVP	Sell	1,242	$85.79	$106,551.18
11/10/2014	Ruediger Naumann-Etienne	Director	Sell	5,000	$85.31	$426,550.00
11/3/2014	Elisha W Finney	CFO	Sell	25,000	$83.82	$2,095,500.00
11/3/2014	Timothy E Guertin	Director	Sell	80,000	$83.72	$6,697,600.00
10/29/2014	Elisha W Finney	CFO	Sell	10,000	$83.95	$839,500.00
10/27/2014	Kolleen T Kennedy	SVP	Sell	1,240	$81.00	$100,440.00
10/1/2014	Elisha W Finney	CFO	Sell	15,000	$79.98	$1,199,700.00
9/11/2014	John W Kuo	SVP	Sell	605	$85.82	$51,921.10
9/2/2014	Elisha W Finney	CFO	Sell	20,000	$85.18	$1,703,600.00
8/20/2014	Venkatraman Thyagarajan	Director	Sell	5,000	$84.25	$421,250.00
8/7/2014	Elisha W Finney	CFO	Sell	5,000	$83.95	$419,750.00
8/1/2014	Elisha W Finney	CFO	Sell	15,000	$81.66	$1,224,900.00
8/1/2014	Timothy E Guertin	Director	Sell	80,000	$81.69	$6,535,200.00
7/9/2014	John W Kuo	SVP	Sell	582	$85.00	$49,470.00
7/1/2014	Elisha W Finney	CFO	Sell	20,000	$83.86	$1,677,200.00
6/23/2014	John W Kuo	SVP	Sell	1,745	$85.00	$148,325.00
6/16/2014	Kolleen T Kennedy	SVP	Sell	1,416	$82.42	$116,706.72
6/2/2014	Elisha W Finney	CFO	Sell	10,000	$82.35	$823,500.00
5/12/2014	Kolleen Kennedy	SVP	Sell	1,417	$81.96	$116,137.32	6,236
5/1/2014	Elisha Finney	CFO	Sell	10,000	$78.99	$789,900.00	4,496
5/1/2014	Timothy Guertin	Director	Sell	80,000	$78.98	$6,318,400.00	48,683
4/11/2014	Kolleen T Kennedy	SVP	Sell	640	$72.15	$46,176.00
4/1/2014	Elisha Finney	CFO	Sell	10,000	$83.97	$839,700.00	4,308
3/17/2014	Clarence Verhoef	SVP	Sell	1,140	$84.70	$96,558.00	768
3/11/2014	Kolleen Kennedy	SVP	Sell	1,417	$84.39	$119,580.63	6,236
3/10/2014	Timothy Guertin	Director	Sell	80,000	$84.05	$6,724,000.00	48,683
3/3/2014	Elisha Finney	CFO	Sell	10,000	$83.41	$834,100.00	4,308
2/21/2014	Mark Laret	Director	Sell	1,411	$84.06	$118,608.66
2/11/2014	Kolleen Kennedy	SVP	Sell	1,416	$80.59	$114,115.44	6,236
2/10/2014	R Andrew Eckert	Director	Sell	5,887	$80.52	$474,021.24	4,983
2/3/2014	Elisha Finney	CFO	Sell	10,000	$79.34	$793,400.00	4,308
2/3/2014	Timothy Guertin	Director	Sell	27,000	$79.34	$2,142,180.00	48,683
1/31/2014	Susan Bostrom	Director	Sell	18,900	$81.50	$1,540,350.00	853
1/2/2014	Elisha Finney	CFO	Sell	24,321	$77.69	$1,889,498.49	4,308
1/2/2014	Richard Levy	Director	Sell	20,000	$77.68	$1,553,600.00
12/30/2013	John Kuo	SVP	Sell	3,027	$77.08	$233,321.16	13,720
12/23/2013	Clarence Verhoef	SVP	Sell	1,297	$76.13	$98,740.61	1,908
12/9/2013	Dow Wilson	CEO	Sell	95,000	$79.09	$7,513,550.00	51,474
12/4/2013	Robert Kluge	SVP	Sell	12,932	$80.00	$1,034,560.00	20,347
12/2/2013	Elisha Finney	CFO	Sell	10,000	$79.04	$790,400.00	8,629
12/2/2013	Richard Levy	Director	Sell	20,000	$79.04	$1,580,800.00
12/2/2013	Robert Kluge	SVP	Sell	9,889	$79.00	$781,231.00	33,279
11/29/2013	Kolleen Kennedy	SVP	Sell	9,307	$78.00	$725,946.00	6,236
11/25/2013	Kolleen Kennedy	SVP	Sell	2,972	$75.49	$224,356.28	6,236
11/22/2013	Elisha Finney	CFO	Sell	1,617	$74.83	$121,000.11	8,629
11/14/2013	Elisha Finney	CFO	Sell	5,000	$74.95	$374,750.00	7,316
11/1/2013	Elisha W Finney	CFO	Sell	5,000	$72.27	$361,350.00
11/1/2013	Richard M Levy	Director	Sell	20,000	$72.27	$1,445,400.00
10/14/2013	Robert Kluge	SVP	Sell	13,889	$78.00	$1,083,342.00	30,121
10/10/2013	Robert Kluge	SVP	Sell	13,871	$77.00	$1,068,067.00	30,121
9/20/2013	Kolleen Kennedy	SVP	Sell	1,247	$76.00	$94,772.00	6,236
9/16/2013	Elisha Finney	CFO	Sell	16,334	$74.95	$1,224,233.30	7,108
9/16/2013	Kolleen Kennedy	SVP	Sell	2,562	$75.00	$192,150.00	7,483
9/11/2013	Elisha W Finney	CFO	Sell	23,666	$74.95	$1,773,766.70
9/3/2013	Elisha Finney	CFO	Sell	5,000	$70.95	$354,750.00	7,108
9/3/2013	Richard Levy	Director	Sell	20,000	$70.95	$1,419,000.00
8/8/2013	Kolleen Kennedy	SVP	Sell	2,400	$73.50	$176,400.00	7,483
8/1/2013	Elisha W Finney	CFO	Sell	5,000	$72.81	$364,050.00
8/1/2013	R Andrew Eckert	Director	Sell	1,375	$72.93	$100,278.75
7/19/2013	John W Kuo	SVP	Sell	1,817	$72.00	$130,824.00
7/17/2013	Richard M Levy	Director	Sell	20,000	$70.00	$1,400,000.00
7/16/2013	Elisha W Finney	CFO	Sell	5,000	$69.95	$349,750.00
6/17/2013	Elisha W Finney	CFO	Sell	5,000	$69.95	$349,750.00
6/17/2013	Richard M Levy	Director	Sell	20,000	$70.00	$1,400,000.00
6/10/2013	Timothy E Guertin	Director	Sell	27,000	$68.81	$1,857,870.00
5/21/2013	Elisha W Finney	CFO	Sell	2,313	$69.86	$161,586.18
5/14/2013	Elisha W Finney	CFO	Sell	5,000	$69.95	$349,750.00
5/14/2013	John W Kuo	SVP	Sell	1,112	$70.00	$77,840.00
5/14/2013	Richard M Levy	Director	Sell	20,000	$70.00	$1,400,000.00
2/14/2013	John W Kuo	SVP	Sell	1,111	$71.05	$78,936.55
9/4/2012	Kolleen T Kennedy	SVP	Sell	1,900	$64.00	$121,600.00
8/20/2012	Elisha W Finney	CFO	Sell	4,000	$59.95	$239,800.00

(Data available from 1/1/2013 forward)

Varian Medical Systems (NYSE VAR) News Headlines

Source:

Date	Headline
	Varian Medical Gets FDA Clearance For Calypso Anchored Beacon Transponder www.nasdaq.com - April 20 at 8:42 AM
	Varian Calypso Anchored Beacon Transponder for Lung Receives FDA 510k Clearance finance.yahoo.com - April 20 at 8:42 AM
	Varian Medical Systems (VAR) Given Average Recommendation of "Hold" by Analysts www.americanbankingnews.com - April 20 at 1:40 AM
	Varian to Demonstrate Advanced Cancer Care Solutions at ESTRO 37 finance.yahoo.com - April 19 at 8:34 AM
	Varian Expands Capabilities of Halcyon Treatment System with New Imaging Technologies finance.yahoo.com - April 19 at 8:34 AM
	Varian Wins "Best After-Sales Service Performance Award for Radiotherapy Products" in China finance.yahoo.com - April 18 at 8:34 AM
	Varian Medical Systems (VAR) SVP John W. Kuo Sells 1,328 Shares www.americanbankingnews.com - April 17 at 7:28 PM
	Varian Medical (VAR) Q2 Earnings: Is a Surprise in Store? finance.yahoo.com - April 17 at 5:40 PM
	Varian Medical Systems (VAR) Scheduled to Post Earnings on Tuesday www.americanbankingnews.com - April 17 at 2:15 AM
	Varian Medical Systems (VAR) & CHF Solutions (CHFS) Head-To-Head Comparison www.americanbankingnews.com - April 16 at 11:11 PM
	$693.86 Million in Sales Expected for Varian Medical Systems (VAR) This Quarter www.americanbankingnews.com - April 16 at 2:35 AM
	Citi Remains Bullish on Varian Medical Systems (VAR) Following 2Q Preview www.streetinsider.com - April 15 at 9:30 AM
	Zacks: Analysts Anticipate Varian Medical Systems (VAR) Will Announce Earnings of $1.03 Per Share www.americanbankingnews.com - April 14 at 5:06 PM
	Medical Equipment Stocks' Research Reports Released on Prestige Brands, Second Sight Medical Products, Senseonics, and Varian Medical Systems www.prnewswire.com - April 12 at 7:30 AM
	Varian Medical (VAR) Launches Velocity 4.0, Shares Rise www.zacks.com - April 11 at 8:53 AM
	Kolleen T. Kennedy Sells 699 Shares of Varian Medical Systems (VAR) Stock www.americanbankingnews.com - April 10 at 7:11 PM
	Varian Medical Systems (VAR) Given a $115.00 Price Target at Royal Bank of Canada www.americanbankingnews.com - April 10 at 12:30 PM
	Here's Why You Should Hold on to Varian Medical Stock Now www.zacks.com - April 10 at 8:50 AM
	Varian Launches Velocity 4.0 Cancer Imaging Software with Selective Internal Radiation Therapy Dosimetry Analysis finance.yahoo.com - April 9 at 8:45 AM
	Oncology Continuum Software: Opportunity for Varian Medical? finance.yahoo.com - April 5 at 5:04 PM
	Software Services: Major Growth Driver for Varian Medical Systems finance.yahoo.com - April 5 at 10:37 AM
	C-RAD to supply advanced surface tracking solution to Swedish Cancer Center Nya Karolinska Solna through Varian Medical Systems globenewswire.com - April 4 at 3:59 PM
	Varian Medical Systems’ Oncology Systems Segment in 2018 finance.yahoo.com - April 4 at 8:40 AM
	Brainlab Announces Interoperability of ExacTrac and Varian’s Edge ® System www.businesswire.com - April 3 at 5:17 PM
	Analyst Recommendations for Varian Medical Systems and Peers finance.yahoo.com - April 3 at 5:17 PM
	Varian Medical Systems: Modest Revenue Growth Expected in 2018 finance.yahoo.com - April 3 at 5:17 PM
	Varian Medical Systems May See Decline in Net Profit Margins finance.yahoo.com - April 3 at 5:17 PM
	Reviewing Varian Medical Systems (VAR) and Capnia (SLNO) www.americanbankingnews.com - April 2 at 7:48 PM
	Varian Medical Systems (VAR) Now Covered by Evercore ISI www.americanbankingnews.com - March 30 at 11:40 PM
	Varian Medical Systems (VAR) Expected to Announce Quarterly Sales of $693.86 Million www.americanbankingnews.com - March 30 at 2:08 AM
	$1.03 EPS Expected for Varian Medical Systems (VAR) This Quarter www.americanbankingnews.com - March 28 at 7:15 PM
	Zacks Investment Research Lowers Varian Medical Systems (VAR) to Hold www.americanbankingnews.com - March 28 at 4:25 PM
	BRIEF-Sirtex Medical Updates On FIRB Approval Regarding Acquisition Of Co By Varian Medical Systems www.reuters.com - March 27 at 8:50 AM
	Varian Eclipse Customers Take Top Overall Spots at World Championships of Treatment Planning finance.yahoo.com - March 27 at 8:50 AM
	Varian Medical Systems, Inc. (VAR) Receives Average Recommendation of "Hold" from Brokerages www.americanbankingnews.com - March 26 at 1:50 AM
	Varian’s Sirtex Acquisition Gets US, German Antitrust Clearances finance.yahoo.com - March 23 at 5:24 PM
	IBA swings to 2017 loss, looks for improvement this year finance.yahoo.com - March 22 at 5:22 PM
	Varian Medical's ProBeam Platform Gains Traction in Russia finance.yahoo.com - March 21 at 5:23 PM
	Medtronic plc (MDT) Ex-Dividend Date Scheduled for March 22, 2018 - Nasdaq www.nasdaq.com - March 21 at 9:21 AM
	Varian-Equipped St. Petersburg Proton Therapy Center Completes First Patient Treatment finance.yahoo.com - March 20 at 8:48 AM
	Here's Why You Should Invest in Varian Medical Right Now - Nasdaq www.nasdaq.com - March 18 at 8:34 AM
	Here's Why You Should Invest in Varian Medical Right Now finance.yahoo.com - March 16 at 6:11 PM
	Here's Why You Should Invest in Varian Medical Right Now finance.yahoo.com - March 16 at 6:11 PM
	Varian Medical Receives Regulatory Nod for Sirtex Buyout - Nasdaq www.nasdaq.com - March 16 at 8:40 AM
	Varian Medical Systems, Inc. (VAR) SVP Sells $166,677.28 in Stock www.americanbankingnews.com - March 15 at 10:08 PM
	Varian Medical Systems (VAR) Upgraded to Buy by Zacks Investment Research www.americanbankingnews.com - March 13 at 2:51 PM
	5 Jefferies Growth Stocks to Buy Have Big Upside Potential www.msn.com - March 13 at 8:47 AM
	Varian (VAR) to Equip 7 Centers in Mexico, Expand in Oncology www.zacks.com - March 13 at 8:47 AM
	Varian Medical Systems, Inc. (VAR) EVP Kolleen T. Kennedy Sells 699 Shares www.americanbankingnews.com - March 12 at 10:44 PM
	Magnus Momsen Sells 1,556 Shares of Varian Medical Systems, Inc. (VAR) Stock www.americanbankingnews.com - March 12 at 10:26 PM

Varian Medical Systems (NYSE:VAR) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Varian Medical Systems (NYSE:VAR) Income Statement, Balance Sheet and Cash Flow Statement

Varian Medical Systems (NYSE VAR) Stock Chart for Friday, April, 20, 2018

Loading chart…

This page was last updated on 4/20/2018 by MarketBeat.com Staff